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A reduction in vascular access flow poses a risk for
thrombosis. We present a new technique to measure vascular
access flow during dialysis based on extracorporeal
temperature gradients, and their changes, on reversing the
extracorporeal bloodlines without having to inject an
indicator. Fistula temperatures were measured by the blood
temperature monitor with normal line position and after
manual switching of the bloodlines using the same
extracorporeal blood flow. The access flow by our
temperature gradient method (TGM) was compared to access
flow derived by saline dilution with measurements in the
same patients repeated in subsequent weeks. In 70 pairs of
TGM and saline dilution measurements in 35 patients, the
repeatability of the TGM measurements was not significantly
different from that of saline dilution. There was a highly
significant correlation between the two techniques with an
acceptable confidence level for limits of agreement for the
difference between them. It took about 9 min to complete
the TGM method and about 5 min for saline dilution. Our
studies show that the novel TGM method showed excellent
agreement and reproducibility with the saline dilution
method without the need for indicator dilution.
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A drop of vascular access flow (Qa) by 25% or a fall below
600 ml/min is considered indicative of pending thrombosis
which should trigger intervention to prevent access throm-
bosis.1
There are several techniques to measure Qa in dialysis
patients during dialysis and most of them are based on
principles of indicator dilution. The measurement by
indicator dilution requires the reversal of extracorporeal
bloodlines, the injection of a suitable indicator such as
isotonic saline into the line returning blood to the access, and
measurement of the dilution curve in the line drawing blood
from the access. The saline dilution technique using reversed
placement of bloodlines has been developed by Krivitski2
approximately 10 years ago. More recently, the use of
thermodilution in access flow monitoring has been intro-
duced.3 A good agreement between the thermodilution and
the saline dilution technique was recently reported, although
the repeatability of saline dilution appeared to be superior to
thermodilution.4
However, the major disadvantage of current techniques is
that they either require manual injection of the indicator
(saline dilution) or that they are slow and time consuming
(thermodilution). The thermodilution technique requires
two measurements with correct and reversed placement of
bloodlines, the algorithms require stability, and the injection
of the thermal indicator (based on changes in dialysate
temperature) takes a few minutes so that the whole procedure
may take up to 30 min. Approximately half of that time the
bloodlines are placed in reversed position. This is too long for
everyday measurements, especially since solute clearance and
treatment efficiency are reduced in the setting where blood
flow is reversed. Moreover, the relatively long time needed for
thermodilution measurements might play a role for its
reduced reproducibility when compared to saline dilution.4
The suggested new technique, the temperature gradient
method (TGM) to measure Qa, is based on the presence of
extracorporeal arterio–venous temperature gradients, and
therefore does not require the injection of an indicator or
thermal bolus. In order to test this new technique, in vivo
measurements were performed and compared to results
obtained by classic saline dilution, considered the reference
technique in this field.
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The aim of this study was first to analyze the agreement
between saline dilution and TGM, secondly to determine the
repeatability of each separate measurement technique, and
thirdly, to determine the time requirements for the new
technique.
RESULTS
The study was performed in 35 vascular accesses (13 forearm
fistula, 9 upper arm fistula, 12 grafts, and 1 upper arm graft)
of 35 end-stage renal disease patients and repeated once.
Therefore, 70 measurement pairs consisting of consecutive
TGM and saline dilution were available for analysis.
Agreement between both techniques
Average Qa measured with the saline dilution technique was
9607594 ml/min and with the TGM 10007588 ml/min
(P¼ns). Correlation between Qa measurements by both
techniques expressed in r2 was 0.930 (r¼ 0.964; Po0.05)
(Figure 1). The limits of agreement for the difference
between TGM and saline dilution were 2–77 ml/min. A
Bland–Altman plot comparing the two techniques is
displayed in Figure 2.
Repeatability results of each separate technique
Repeatability of saline dilution and TGM measurements
within a weekly interval, expressed as a relative difference
(DXrel) was 15.4714.3 and 20.6719.4%, respectively
(P¼ns). The absolute difference between consecutive TGM
and saline dilution measurement results is presented in a
histogram (Figure 3).
The correlation of subsequent measurements expressed as
r2 was 0.88 (r¼ 0.94) for saline dilution, and 0.85 (r¼ 0.92)
for TGM, respectively.
Additional results
The mean relative difference between the extracorporeal
blood flow (Qb) measured by both techniques was 4.773.4%
(70 measurements).
Arterial line temperature in reversed line position (Tart,x)
(70 registrations) stabilized within 3 and 9.15 min after
having reversed the bloodlines (Figure 4). Stabilization was
achieved when temperatures remained stable (meaning the
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Figure 1 | Correlation between saline dilution and TGM. Qa, access
flow; TGM, temperature gradient method.
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Figure 2 | Bland-Altman saline dilution/TGM. Qa, access flow;
TGM, temperature gradient method, dotted lines refer to two times
the standard deviation of the mean relative difference.
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Figure 3 | Absolute difference between consecutive TGM and
saline dilution measurements.
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exact same temperature) for at least 1 min, counting from
2.5 min after line reversal.
The average fluctuation of venous line temperature in
reversed line position (Tven,x) (70 registrations), registered
from 2 to 10 min after line reversal, was 0.02170.0101C.
The average duration to measure Qa with saline dilution
was 5.170.7 min, counted from the time of stopping Qb,
reversing the bloodlines, preparing the dilution, waiting for
the result, and switching lines back to normal position. The
average duration to measure Qa with the TGM technique was
8.973.5 min (Po0.05), counted from the time of registering
arterial line temperature in normal line position (Tart,n),
reversing the bloodlines, registering Tart,x, Tven,x, extracorpo-
real blood pump speed in reversed line position (Qb,x) after
stabilization, and switching lines back to normal position.
The mean arterial pressures (MAP) at which the
repeatability tests were performed for saline dilution Qa
measurements were 84.0721.2 mm Hg (week 1) and
83.4717.7 mm Hg (week 2), respectively.
The MAP at which the repeatability tests were performed
for TGM access flow measurements were 86.1723.2 mm Hg
(week 1) and 85.5719.1 mm Hg (week 2), respectively.
Within saline dilution and within TGM and between saline
dilution and TGM there were no significant differences in
MAP between week 1 and week 2.
DISCUSSION
In this study a new and abridged technique to measure access
flow based on extracorporeal temperature gradients during
dialysis was compared to the saline dilution technique. The
comparison showed a high correlation of measurements
obtained by TGM and saline dilution techniques and a high
reproducibility of subsequent weekly measurements. More-
over, the TGM Qa measurement was quick and simple, as it is
no longer required to inject an indicator (either manually or
automatically).
This new technique to measure vascular access flow has
several advantages compared to the thermodilution techni-
que, reported previously. First, the TGM technique is less
time consuming: 8.973.5 min, whereas the thermodilution
measurement takes 2977 min to perform one access flow
measurement.4 Second, the TGM does not require the
injection of indicator which simplifies the measurement.
Third, the correlation coefficient of subsequent measure-
ments (r¼ 0.92) appears to be comparable or even better to
the original thermodilution technique (Lopot et al.5 r¼ 0.92;
Wijnen et al.4 r¼ 0.89; and Ragg et al.6 r¼ 0.68). As opposed
to the thermodilution technique4 TGM reproducibility
expressed in relative difference (DXrel) did not significantly
differ from the saline dilution reproducibility (20.6719.4
and 15.4714.3%, respectively (P¼ns)).
An important remark has to be made regarding reprodu-
cibility. It is difficult to assess in vivo reproducibility of
techniques measuring access flow because of the duration of
the measurements and because of possible hemodynamic
changes which by themselves will influence access flow.7
Access flow can be assumed to follow Poiseuille’s Law and to
depend on access resistance, on in- and outflow pressures of
the access loop, and on rheologic properties of blood. Access
resistance represents the sum of serial resistances from the
level of the arterial anastomosis to the venous outflow and
the central venous conduit.8 In a first approximation one can
assume that access resistance is not actively controlled during
hemodialysis and therefore remains more or less stable within
the same dialysis treatment as shown previously.9 A similar
consideration applies to the rheologic properties of blood.
Even though hematocrit increases during hemodialysis and
ultrafiltration, the effect of increasing blood viscosity on
access flow can be considered as negligible. Thus, the major
factor causing acute changes in access blood flow is the
driving pressure across the access loop, which is governed by
MAP. Therefore, if MAPs are comparable among measure-
ments, access blood flows are also likely to be comparable
within the same treatment and likely to be comparable within
subsequent treatments.
This study was designed to compare the TGM with the
currently accepted reference technique (saline dilution). To
obtain an idea of measurement quality, apart from studying
the agreement between the two described techniques, weekly
interval reproducibility was studied at the same mean arterial
blood pressure to exclude variation caused by differences in
hemodynamic conditions.
An impression of weekly Qa variation at the same MAP
can be illustrated by analyzing the reproducibility of the
saline dilution technique: Depner and Krivitski10 found a
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Figure 4 | Stabilization analysis of Tart,x. Distribution of time
delays (in increments of 15 s) to reach stable arterial temperatures
(exact same arterial temperature for at least 1 min) after having
switched the bloodlines. Tart,x¼ temperature in the arterial bloodline
after line reversal, n¼ number of Tart,x stabilization moments after line
reversal (total n¼ 70).
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relative difference of 5.073.8% (n¼ 110) in two measure-
ments performed within 2 min. As in the authors dialysis
unit, routine Qa measurements (saline dilution) are carried
out in triplicate, we were able to analyze reproducibility as
well. Five hundred randomized subsequent measurements in
a broad flow range (290–3120 ml/min) were analyzed. Saline
dilution reproducibility (6.974.8%) was comparable with
the results found by Depner and Krivitski. Weekly interval
reproducibility of saline dilution in this study (15.4714.3%)
and in Wijnen et al.4 (13711%) roughly differed by 8–10%
compared to previously described reproducibility results
(6.974.8 and 5.073.8%, authors and Depner’s analysis,
respectively).
The reproducibility of both measuring techniques in this
study suggests that a sizable fraction of patients might
have had a Qa change of more than 25% from the preceding
value, and in case of a 25% decline or more this would
have been an indication for pre-emptive intervention. Out of
the 35 included patients, there were 4 patients with a
relatively large Qa increase in week 2 compared to week 1,
measured with the saline dilution technique (47%, i.e., from
1060 to 1560 ml/min, in week 1 vs week 2, respectively;
43%, i.e., from 860 to 1230 ml/min; 55%, i.e., from 420 to
660 ml/min; and 45%, i.e., from 820 to 1190 ml/min,
respectively). These data correlate with historic Qa results
obtained by standard Qa surveillance measurements (ob-
tained by saline dilution) that showed similar flow variations
over monthly measurements. The four described patients all
had native fistulas, which supports the assumption that
native fistulas have a more variable flow pattern compared to
grafts.
Only one patient had a Qa decline of more than 25%
(32%). Qa in this patients’ graft was recognized as low
(7300 ml/min) and was accepted because a recently
performed radiological intervention did not increase flow,
besides the patient was seen with very low blood pressures
(B80/50). This patient was deliberately included for known
low blood flow. Qa results for this patient by both techniques
were 333 and 280 ml/min at week 1 by TGM and saline
dilution, respectively, and 230 and 190 ml/min at week 2 by
TGM and saline dilution, respectively.
Apart from the described Qa decline of more than 25%, we
observed one more Qa decline in a graft obtained by TGM
(31%, from 1350 to 933 ml/min, in week 1 vs week 2,
respectively), which would have been the only indication for
intervention in all accesses studied. Based on the saline
dilution measurement (780 and 810 ml/min) no action was
taken.
We observed four increased flows (425%) obtained with
the TGM in four arteriovenous fistula: 33% (from 1355 to
1799 ml/min, in week 1 vs week 2, respectively), 34% (from
2449 to 3273 ml/min), 32% (from 314 to 415 ml/min), and
40% (from 929 to 1300 ml/min).
The results of the TGM technique correlated closely with
the results of the saline dilution technique (r¼ 0.96). So far,
most other on-line access flow measurement techniques
showed less or inferior correlation. Lopot et al.5 compared
the saline dilution technique with thermodilution (r¼ 0.95),
opto-dilutional reversed lines measurement (r¼ 0.70), and
direct opto-dilutional access flow evaluation from step-
changes in ultrafiltration rate (r¼ 0.70), although Yarar
et al.11 found a better correspondence to the saline dilution
technique with this ultrafiltration method (r¼ 0.92). Ram
et al.12 compared the saline dilution method with the glucose
pump test (r¼ 0.91). Recently, another technique to measure
access flow bypassing the injection of a marker was
presented.13 This technique is based on the measurement of
effective urea clearance and on the change in urea dialysate
concentrations caused by reversing the extracorporeal blood-
lines. Two variants of this approach were tested and the
results correlated well with saline dilution, with r¼ 0.92 and
0.94, respectively. However, this technique requires the
presence of an on-line urea sampling device and the authors
did not report the time requirements for this new test.
Stabilization in dialysate concentrations is likely to be delayed
in comparison to blood concentrations or temperatures
because of considerable additional dead space between the
access and the measuring sites.
The accuracy of Qa measurements using the TGM
technique importantly depends on the stability of dialysate
flow and dialysate temperature. When dialysate flow is
temporarily interrupted, this is reflected in changes in venous
line temperature Tven,x which will affect the accuracy of the
access flow measurement. During this study, dialysate flow
was constant. Fluctuations in Tven,x appeared to be limited to
an average of 0.02170.0101C.
Figure 4 shows that arterial temperature Tart,x stabilized
within 10 min; however, no clear relationship between
experimental conditions such as patient temperatures or
access flows and the duration to reach stable readings could
be recognized.
As described in the Materials and Methods section,
dialysate temperature was set at 35.51C. This temperature
was chosen to establish a significant difference between Tart
and Tven. When the gradient between Tart and Tven narrows,
the calculation of Qa (equation 1) can be expected to be less
accurate due to the finite temperature resolution of the blood
temperature monitor (BTMs, Fresenius Medical Care
Germany, Bad Homburg, Germany) temperature measure-
ment. Standard dialysate settings in approximately one-third
of the included patients include standard dialysate tempera-
tures of 35.51C to obtain hemodynamic stability during
dialysis treatment. Although a low dialysate temperature may
result in coldness and shivering, none of the included
patients, even in patients who are normally dialysed against a
higher dialysate temperature, complained of uncomfortable
sensations. Measurements were performed during the first
hour of dialysis and temperature settings were returned to
their normal settings after the access flow measurements.
Although no data are available in the literature, less than 1 h
of dialysate temperatures at 35.51C in our study does not
seem to provoke any uncomfortable sensation. Nor have we
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seen a significant blood pressure increase in patients with the
dialysate temperature set at 35.51C. On the contrary,
choosing a higher dialysate temperature to achieve a similar
temperature gradient but in the opposite direction might
provoke a decrease in blood pressure, while lower dialysate
temperature settings are more or less a means to maintain
blood pressure stability. This is the reason why we
deliberately chose to create a sufficient temperature gradient
through ‘cold’ dialysis.
The effect of low dialysate temperature on access blood
flow has not been studied systematically, as far as we know.
Most access flow measurements have been carried out (and
are still performed) under unknown temperature conditions.
It is only with the BTM used in this study that thermal effects
caused by dialysis can be adequately measured and
controlled, but there are no reports on this topic. If at all,
we expect an indirect effect of cool or warm dialysis on access
flow caused by differences in arterial pressure, as blood flow
through the vascular access is not directly controlled by
vasoconstriction or vasodilatation. As mentioned earlier, cool
dialysate will help to maintain blood pressure and may
therefore help to prevent access blood flow from dropping
during hemodialysis. But as measurements were carried out
early in dialysis, effects of extracorporeal cooling or warming
will be of minor importance at that stage of dialysis.
The use of a switch to reverse the extracorporeal
bloodlines integrated in some extracorporeal tubing sets
(e.g., the Reversos; Medisystems Corporation, Seattle, WA,
USA) might further simplify the TGM measurement. When
Qb is not interrupted, stabilization of temperatures might
occur earlier in time. Moreover, specific software, integrated
in the dialysis machine, could register the temperature
stabilization and based on the other gathered variables,
automatically calculate Qa. In an in vitro model, Schneditz
et al.14 showed that it is even possible to shorten the
measuring time by analyzing the whole-time course of
arterial and venous line temperatures. Use of integrated
software would not just simplify the measurement but would
also prevent errors related to manual measurement.
In conclusion, TGM Qa measurements significantly
correlated with the saline dilution Qa measurements. This
new BTM technique of manually switching lines results in an
accurate measure of Qa, with a reproducibility comparable to
results obtained by saline dilution, however, without the
requirement to inject an indicator.
Considering the described technical aspects and the size of
this study, additional studies are required before the TGM
technique to measure vascular access flow is recommended
for widespread use.
MATERIALS AND METHODS
Protocol
Qa measurements were performed once by each separate measuring
technique during the first hour of dialysis. Dialysate temperature
was set at 35.51C. Temperatures were measured by the BTM. First,
Tart,n and venous bloodline temperatures (Tven,n) were registered
after stabilization of temperatures with lines in normal position
(indicated by the subscript n). Secondly, extracorporeal lines were
reversed and Tart,x, Tven,x, and effective Qb,x were registered after
stabilization of BTM temperatures. Temperature stabilization after
line reversal was detected by continuous temperature monitoring for
a duration of up to 10 min. After TGM measurements, Qa was
measured using the saline dilution technique (HD01, Transonics,
Transonic Systems Inc., Ithaca, NY, USA). Blood pressure was
measured before each access flow measurement. Measurements were
carried out at an extracorporeal blood flow of 300 ml/min as advised
by the reference technique. Each vascular access was studied twice
with an interval of 1 week between measurements. All patients gave
informed consent to participate in this study.
Analysis techniques
Saline dilution. Measuring access flow using saline dilution, a
bolus of isotonic saline (indicator) is administrated into the venous
bubble trap after line reversal. Two ultrasound dilution sensors are
clamped onto the bloodlines, one on the arterial and one on the
venous bloodline. The venous saline dilution sensor will first sense
the diluted blood used as a reference value to calculate the actual
recirculation (R) of saline entering the arterial line.
Besides sensing dilution, the ultrasound sensors simultaneously
measure blood flow in the bloodlines (Qb). Qa can now be calculated
with the formula Qa¼Qb ((1R)/R).
Temperature gradient method. When bloodlines are reversed,
the arterial temperature Tart,x leaving the access is the result of the
mixture of access inflow temperature and the temperature of venous
line blood returning to the access (Figure 5).
With help of previous described variables, Qa can be calculated.
Mathematically this relationship is represented as:
Qa ¼ Qb;x  UFR
 Tart;x  Tven;x
Tart;n  Tart;x
The measurement of Qa therefore requires the measurement of
arterial and venous line temperatures with correct and reversed
placement of bloodlines in the presence of arterio–venous
temperature gradients. Since arterial and venous temperatures are
continuously measured in the current BTM configuration, the
TQdiaTven,x
T
ve
n
,x
T
a
rt,x
Tart,nTpatient
Qb,x
Qa
T mixing zone
≈
≈
Figure 5 | Reversed line measurement set-up TGM. Qa, access flow;
Qb,x, extracorporeal blood flow when lines are reversed; Tven,x,
temperature in the venous bloodline; Tart,n, temperature in the
arterial bloodline before line reversal; Tart,x, temperature in the arterial
bloodline after line reversal; TQdia , dialysate temperature; Tpatient,
patient temperature. The mixture of Tven,x and Tpatient between the
needles caused by forced recirculation when lines are switched is
reflected in Tart,x.
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measurement of Qa only requires to reverse the arterial and venous
line and to measure the step-change in arterial line temperature.
A more detailed description of the TGM is described elsewhere.14,15
Dialysis strategy
Patients were either treated with bicarbonate hemodialysis with low
flux polysulfone membranes (F8HPS; Fresenius, Bad Homburg,
Germany) (n¼ 31) or with on-line postdilution hemodiafiltration
with high flux membranes (APS-1050, Asahi Medical Co, Tokyo,
Japan) (n¼ 4). Postdilution hemodiafiltration has no effect on BTM
measurement as the substitution fluid is from the same source as the
dialysate. Thus changing the dialysate temperature also affects the
substitution fluid temperature in the same way. Using the Transonic
HD01, infusion of substitution fluid was temporarily stopped
because it interferes with the venous line ultrasound signal.
Sodium concentration of the dialysate was 138 or 140 mmol/l,
calcium concentration was 1.5 mmol/l, and temperature of the
dialysate was set at 35.51C. Ultrapure dialysate was used.
Statistical analysis
Statistical analysis was performed using SPSS 12.01 software (SPSSs
Inc., Chicago, IL, USA). Correlations between vascular access flow
measured by different methods were estimated by Pearson product
moment correlations. A Bland and Altman plot was used to visually
assess agreement between the different methods. The repeatability of
both techniques was assessed by analyzing the relative difference of
weekly subsequent measurements:
DXrel ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðX2=X1  1Þ2
q 
100
Data are expressed as mean7s.d. Po0.05 were considered
significant.
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